Ki-67 antigen expression as a prognostic factor in primary and recurrent astrocytomas

Neurochirurgie

Volumn 44, Issue 1, 1998, Pages 25-30

  Enestrom S ^a   Vavruch, L ^a   Franlund B ^a   Nordenskjold B ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Ki 67; Prognostic indicators; Recurrent astrocytomas

Indexed keywords

KI 67 ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER SURVIVAL; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; RECURRENT CANCER;

ADULT; AGED; ASTROCYTOMA; BRAIN; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; SURVIVAL ANALYSIS;

EID: 0031941859     PISSN: 00283770     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. ARMITAGE P, BERRY G. Statistical methods in medical research, Oxford, Blackwell Scientific Publications, 1987.
2. BROWN DC, GATTER KC. Monoclonal antibody Ki-67 : its use in histopathology. Histopathology 1990 ; 17 : 489-503.
3. BURGER PC, SCHEITHAUER BW. Tumors of the central nervous system. Atlas of tumor pathology, third series, fascicle 10. Washington, DC : Armed Forces Institute of Pathology, 1994.
4. BÖKER DK, STARK HJ. The proliferationrate of intracranial tumors as defined by the monoclonal antibody Ki 67. Application of the method to paraffin embedded specimens. Neurosurg Rev 1988 ; 11 : 267-272.
5. CATTORETTI G, PILERI S, PARRAVICINI C, BECKER MH, PAGGI S, BIFULCO C et al. Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J Pathol 1993 ; 171 : 83-98.
6. COONS SW, JOHNSON PC. Regional heterogeneity in the DNA content of human gliomas. Cancer 1993 ; 72 : 3052-3060.
7. ELLISON DW, STEART PV, BATEMAN AC, PICKERING RM, PALMER JD, WELLER RO. Prognostic indicators in a range of astrocytic tumours : an immunohistochemical study with Ki-67 and p53 antibodies. J Neurol Neurosurg Psychiatry 1995 ; 59 : 413-419.
8. JAROS E, PERRY RH, ADAM L, KELLY PJ, CRAWFORD PJ, KALBAG RM et al. Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours. Br J Cancer 1992 ; 66 : 373-385.
9. KARAMITOPOULO E, PERENTES E, DIAMANTIS I, MARAZIOTIS T. Ki-67 immunoreactivity in human central nervous system tumors: a study with MIB 1 monoclonal antibody on archival material. Acta Neuropathol (Berl) 1994 ; 87 : 47-54.
10. KEY G, BECKER MH, BARON B, DUCHROW M, SCHLUTER C, FLAD HD et al. New Ki-67-equivalent murine monoclonal antibodies (MIB1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab Invest 1993 ; 68 : 629-636.
11. LANDBERG G. Proliferation associated nuclear antigens. A flow cytometric study with special reference to proliferating cell nuclear antigen (PCNA) and Ki-67 antigen. Umeå : Umeå University medical dissertations, 1991 ; New series No 319.
12. MONTINE TJ, VANDERSTEENHOVEN JJ, AGUZZI A, BOYKO OB, DODGE RK, KERNS BJ et al. Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms. Neurosurgery 1994 ; 34 : 674-678.
13. PARENT M, BLOND S, GOSSET P, LEJEUNE JP, LESOIN F, DHELLEMMES P et al. Cellular kinetics of cerebral gliomas: study of the proliferative activity using monoclonal antibody Ki 67. Report of 60 cases. Arch Anat Cytol Pathol 1990 ; 38 : 81-85.
14. POLLACK IF, CAMPBELL JW, HAMILTON RL, MARTINEZ AJ, BOZIK ME. Proliferation index as a predictor of prognosis in malignant gliomas of childhood. Cancer 1996 ; 79 : 849-856.
15. RAGHAVAN R, STEART PV, WELLER RO. Cell proliferation patterns in the diagnosis of astrocytomas, anaplastic astrocytomas, and glioblastoma multiforme : a Ki-67 study. Neuropathol Appl Neurobiol 1990 ; 16 : 123-133,
16. SALLINEN PK, HAAPASALO HK, VISAKORPI T, HELÉN PT, RANTALA IS, ISOLA JJ et al. Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA. and S-phase fraction using archival paraffin-embedded samples. J Pathol 1994 ; 174 : 275-282.
17. VAVRUCH L, NORDENSKJÖLD B, CARSTENSEN J, ENESTROM S. Prognostic value of flow cytometry and correlation to some conventional prognostic factors: A retrospective study of archival specimens of 134 astrocytomas. J Neurosurg 1996 ; 85 : 146-151.
18. WAKIMOTO H, AOYAGI M, NAKAYAMA G, YAMAMOTO S, TAMAKI M, HIRAKAWA K. Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas. Cancer 1996 ; 77 : 373-380.